| Source: |
| Type: |
| COX‑1 is traditionally considered a constitutively expressed enzyme involved in “housekeeping” functions, while COX‑2 is more frequently studied in relation to cancer. • The prognostic impact of COX‑1 may vary based on cancer subtype, stage, and interplay with other inflammatory mediators (e.g., COX‑2). • Many studies assess combined cyclooxygenase profiles (COX‑1/COX‑2) rather than COX‑1 alone. |
| none (reserved) |
| 2461- | ASA, | Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis |
| - | Review, | NA, | NA |
| 5412- | ASA, | Clinical Pharmacology of Aspirin |
| - | Review, | NA, | NA |
| 1096- | ASA, | Aspirin inhibit platelet-induced epithelial-to-mesenchymal transition of circulating tumor cells (Review) |
| - | Review, | NA, | NA |
| 4342- | CA, | Antiplatelet effects of caffeic acid due to Ca(2+) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation |
| - | in-vitro, | NA, | NA |
| 2563- | EGCG, | Cardioprotective effect of epigallocatechin gallate in myocardial ischemia/reperfusion injury and myocardial infarction: a meta-analysis in preclinical animal studies |
| - | Review, | NA, | NA |
| 3250- | PBG, | Allergic Inflammation: Effect of Propolis and Its Flavonoids |
| - | Review, | NA, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:0 Cells:% prod#:% Target#:998 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid